FDA Approves First Motorized Exoskeleton For Personal Use
ReWalk system will offer rehabilitation and higher quality of life for US paraplegics.
Sufferers of lower-body paralysis (paraplegia) will soon have access to ReWalk, a motorized exoskeleton controlled by the user and enabling them to walk, sit, stand, and even climb stairs. Developed and sold by ReWalk Robitics (formerly Argo Medical Technologies), the product was approved for clinical use in the US in 2011, but will now be available for personal use throughout the country.
While many companies are racing to find treatments for patients suffering from the results of spinal cord injury (SCI), ReWalk, with its non-invasive design, is the first device of its kind available for widespread and at-home use in Europe and, as of now, in the US as well.